Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Hossein Tezval"'
Autor:
Olga Katzendorn, Inga Peters, Natalia Dubrowinskaja, Hossein Tezval, Pouriya Faraj Tabrizi, Christoph A. von Klot, Jörg Hennenlotter, Marcel Lafos, Markus A. Kuczyk, Jürgen Serth
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background DNA methylation is frequently observed in the development and progression of many human tumors as well as renal cell cancer (RCC). Tumor Associated Calcium Signal Transducer 2 (TACSTD2) participates in cell cycle progression throu
Externí odkaz:
https://doaj.org/article/177404d0eda24c7eb89204fddace0e08
Autor:
Olga Katzendorn, Christoph A J von Klot, Samy Mahjoub, Pouriya Faraj Tabrizi, Nina N Harke, Hossein Tezval, Susanne Hellms, Jörg Hennenlotter, Mirza S Baig, Arnulf Stenzl, Ferdinand Seith, Marcel Lafos, Markus A Kuczyk, Steffen Rausch, Inga Peters
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0271981 (2022)
Available tests to detect clinically significant prostate cancer frequently lead to overdiagnosis and overtreatment. Our study assessed the feasibility of combining a urinary biomarker-based risk score (SelectMDx®) and multiparametric MRI outcomes i
Externí odkaz:
https://doaj.org/article/ceafe639f0a740e79b64ecad149effb7
Autor:
Maren B. Pfenning, Jessica Schmitz, Irina Scheffner, Kevin Schulte, Abedalrazag Khalifa, Hossein Tezval, Alexander Weidemann, Anke Kulschewski, Ulrich Kunzendorf, Sebastian Dietrich, Hermann Haller, Jan T. Kielstein, Wilfried Gwinner, Jan H. Bräsen
Publikováno v:
Kidney International Reports. 8:341-356
Autor:
Nina N. Harke, Sarah Strauss, Inga Peters, Olga Katzendorn, Hossein Tezval, Markus A. Kuczyk, Peter M. Vogt
Publikováno v:
World Journal of Urology.
Autor:
Markus A. Kuczyk, Natalia Dubrowinskaja, Hossein Tezval, Olga Katzendorn, Jürgen Serth, Inga Peters, Pouriya Faraj Tabrizi, Jörg Hennenlotter, Marcel Lafos, Christoph A. J. von Klot
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Cancer
BMC Cancer
Background DNA methylation is frequently observed in the development and progression of many human tumors as well as renal cell cancer (RCC). Tumor Associated Calcium Signal Transducer 2 (TACSTD2) participates in cell cycle progression through MAPK s
Autor:
Hossein Tezval, Natalia Dubrowinskaja, Inga Peters, Christel Reese, Katrin Serth, Faranaz Atschekzei, Jörg Hennenlotter, Arnulf Stenzl, Markus A Kuczyk, Jürgen Serth
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0163873 (2016)
The relevance of Corticotropin Releasing Hormone (CRH)-system in human malignancies is a question of growing interest. Here we investigated hypermethylation and epigenetic silencing of the CRH-Binding Protein (CRHBP) gene in clear cell renal cell can
Externí odkaz:
https://doaj.org/article/aa0307a1971c4de8a67afe2d65a10127
Autor:
Olga Katzendorn, Inga Peters, Natalia Dubrowinskaja, Joana M. Moog, Christel Reese, Hossein Tezval, Pouriya Faraj Tabrizi, Jörg Hennenlotter, Marcel Lafos, Markus A. Kuczyk, Jürgen Serth
Publikováno v:
Cancers
Cancers; Volume 14; Issue 1; Pages: 39
Cancers, Vol 14, Iss 39, p 39 (2022)
Cancers; Volume 14; Issue 1; Pages: 39
Cancers, Vol 14, Iss 39, p 39 (2022)
Simple Summary Early prediction of aggressive cancer using biomarkers is thought to be important for future improvements in the personalized treatment of renal cell carcinoma (RCC). Epigenetic alterations, such as DNA methylation, are promising candi
Publikováno v:
Brazilian Journal of Cardiovascular Surgery, Vol 20, Iss 3, Pp 336-339 (2005)
Neste trabalho é apresentado um caso de coexistência de aterosclerose aorto-ilíaca com rim em ferradura, em um homem com 57 anos de idade. O diagnóstico desta combinação rara foi feito pouco antes da cirurgia, com a angio-ressonância magnétic
Externí odkaz:
https://doaj.org/article/5f0d3c85f23242eda95f746f2b0d31d7
Autor:
Jürgen Serth, Hossein Tezval, Markus A. Kuczyk, Anahit Mohebbi Tafrechi, Faranaz Atschekzei, Pouriya Faraj Tabrizi, Inga Peters
Publikováno v:
Advances in Therapy. 37:288-299
INTRODUCTION: The corticotropin-releasing hormone (CRH) system, its receptors corticotropin-releasing hormone receptor 1 (CRHR1) and 2 (CRHR2), and its corresponding binding protein corticotropin-releasing hormone-binding protein (CRHBP) as well as t
Autor:
Jürgen Serth, Inga Peters, Olga Katzendorn, Tu N. Dang, Joana Moog, Zarife Balli, Christel Reese, Jörg Hennenlotter, Alexander Grote, Marcel Lafos, Hossein Tezval, Markus A. Kuczyk
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 19; Pages: 11190
Approximately 21% of patients with renal cell cancer (RCC) present with synchronous metastatic disease at the time of diagnosis, and metachronous metastatic disease occurs in 20–50% of cases within 5 years. Recent advances in adjuvant treatment of